Role of N-linked glycosylation in biosynthesis, trafficking, and function of the human glucagon-like peptide 1 receptor.
The family B G protein-coupled glucagon-like peptide 1 (GLP-1) receptor is an important drug target for treatment of type 2 diabetes. Like other family members, the GLP-1 receptor is a glycosylated membrane protein that contains three potential sites for N-linked glycosylation within the functionally important extracellular amino-terminal domain. However, the roles for each potential site of glycosylation in receptor biosynthesis, trafficking, and function are not known. In this work, we demonstrated that tunicamycin inhibition of glycosylation of the GLP-1 receptor expressed in CHO cells interfered with biosynthesis and intracellular trafficking, thereby eliminating natural ligand binding. To further investigate the roles of each of the glycosylation sites, site-directed mutagenesis was performed to eliminate these sites individually and in aggregate. Our results showed that mutation of each of the glycosylation sites individually did not interfere with receptor expression on the cell surface, ligand binding, and biological activity. However, simultaneous mutation of two or three glycosylation sites resulted in almost complete loss of GLP-1 binding and severely impaired biological activity. Immunostaining studies demonstrated receptor biosynthesis but aberrant trafficking, with most of the receptor trapped in the endoplasmic reticulum and golgi compartments and little of the receptor expressed on the cell surface. Interestingly, surface expression, ligand binding, and biological activity of these mutants improved significantly when biosynthesis was slowed using low temperature (30 degrees C). These data suggest that N-linked glycosylation of the GLP-1 receptor is important for its normal folding and trafficking to the cell surface.
Chen
Quan
Q
Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, 13400 East Shea Blvd., Scottsdale, AZ 85259, USA.
Miller
Laurence J
LJ
Dong
Maoqing
M
D000818:Animals; D001665:Binding Sites / Q000502:physiology*; D016466:CHO Cells; D002462:Cell Membrane / Q000378:metabolism; D006224:Cricetinae; D003412:Cricetulus; D052216:Glucagon-Like Peptide 1 / Q000096:biosynthesis / Q000378:metabolism*; D006031:Glycosylation / Q000187:drug effects; D006801:Humans; D007150:Immunohistochemistry; D016297:Mutagenesis, Site-Directed; D010446:Peptide Fragments / Q000096:biosynthesis / Q000378:metabolism*; D017510:Protein Folding; D014162:Transfection; D014415:Tunicamycin / Q000494:pharmacology*
D010446:Peptide Fragments; D014415:Tunicamycin; C055453:glucagon-like peptide 1 (7-36)amide; D052216:Glucagon-Like Peptide 1
Biochemistry. 2000 May 30;39(21):6514-20
10828967
Annu Rev Biochem. 1988;57:785-838
3052290
J Biol Chem. 1984 Aug 25;259(16):10414-21
6088499
J Biol Chem. 1994 Aug 5;269(31):19738-44
8051054
Hum Reprod Update. 1999 Jul-Aug;5(4):356-64
10465525
Gastroenterology. 1993 Nov;105(5):1534-43
8224659
Biochim Biophys Acta. 2001 May 28;1539(1-2):131-9
11389975
J Mol Neurosci. 2008 Nov;36(1-3):279-85
18401761
Biochemistry. 1996 Feb 13;35(6):1745-52
8639654
Am J Physiol Endocrinol Metab. 2001 Nov;281(5):E1015-21
11595658
Mol Endocrinol. 2008 Jun;22(6):1489-99
18372345
J Biol Chem. 2009 Dec 4;284(49):34135-44
19815559
Pharmacol Ther. 2007 Mar;113(3):546-93
17306374
Biochemistry. 2009 Dec 15;48(49):11773-85
19886671
Endocrinology. 1999 Nov;140(11):5102-11
10537138
Anal Biochem. 1980 Sep 1;107(1):220-39
6254391
Peptides. 1994;15(4):675-81
7937345
Br J Pharmacol. 2010 Jan;159(1):237-51
20002095
J Biol Chem. 1998 Dec 18;273(51):34558-67
9852126
Biol Chem. 2004 Jan;385(1):49-57
14977046
J Biol Chem. 1996 Jun 21;271(25):14944-9
8663161
Pancreas. 1996 Aug;13(2):130-9
8829180
FEBS Lett. 2000 Dec 15;486(3):320-4
11119727
J Biol Chem. 2010 Jan 1;285(1):723-30
19861722
Biochemistry. 1999 Feb 9;38(6):1866-72
10026267
Biochemistry. 1999 Jul 6;38(27):8621-7
10393537
Biochem Biophys Res Commun. 2006 Feb 10;340(2):395-402
16364240
Biochemistry. 1996 Dec 10;35(49):15890-5
8961954
Mol Endocrinol. 2004 Jul;18(7):1768-77
15105436
J Biol Chem. 2008 Apr 25;283(17):11340-7
18287102